Yamada T, Hayashi Y, Kaneko R, Tohnai I, Ueda M, Ito M
Department of Oral Surgery, Nagoya University School of Medicine, Japan.
J Radiat Res. 1998 Jun;39(2):101-9. doi: 10.1269/jrr.39.101.
Hyperthermia is being investigated as a cancer treatment. Many of its basic mechanisms, particularly those related to cell killing, are still poorly understood. We used a transplanted squamous cell carcinoma cell line to investigate the therapeutic effect of hyperthermia. In particular, we examined the effect of OK-432 (biological response modifier) on hyperthermia-induced apoptosis. In the hyperthermia only group the most extensive necrosis occurred on day 3 (70.3%), and the apoptosis index also was highest on that day (69.3). These results suggest that the induction of apoptosis is closely related to the cell death caused by hyperthermia. The percent of necrosis was significantly higher in the groups given hyperthermia and combined OK-432 and hyperthermia treatment than in the OK-432 group (p < 0.05). The apoptosis index was significantly lower in the combined OK-432 and hyperthermia treatment group than in the hyperthermia only group, indicative that the antitumor effect of combined hyperthermia and OK-432 therapy is not ascribable to the induction of apoptosis.
热疗作为一种癌症治疗方法正在进行研究。其许多基本机制,尤其是那些与细胞杀伤相关的机制,仍了解甚少。我们使用一种移植的鳞状细胞癌细胞系来研究热疗的治疗效果。特别地,我们研究了OK-432(生物反应调节剂)对热疗诱导的细胞凋亡的影响。在单纯热疗组中,第3天出现最广泛的坏死(70.3%),且当天的凋亡指数也最高(69.3)。这些结果表明,细胞凋亡的诱导与热疗引起的细胞死亡密切相关。热疗联合OK-432组和热疗联合治疗组的坏死百分比显著高于OK-432组(p < 0.05)。热疗联合OK-432治疗组的凋亡指数显著低于单纯热疗组,表明热疗与OK-432联合治疗的抗肿瘤作用并非归因于细胞凋亡的诱导。